Journal
HEPATOLOGY
Volume 61, Issue 5, Pages 1603-1614Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1002/hep.27682
Keywords
-
Categories
Funding
- National Key Sci-Tech Project [2012ZX10002011-002]
- National Natural Science Foundation of China [81472840, 81172023, 81071741, 81030038]
- Shanghai Municipal Natural Science Foundation [14ZR1405800]
- Ph.D. Programs Foundation of the Ministry of Education of China [20110072120050]
Ask authors/readers for more resources
The prognosis for hepatocellular carcinoma (HCC) remains dismal in terms of overall survival (OS), and its molecular pathogenesis has not been completely defined. Here, we report that expression of deubiquitylase ubiquitin-specific protease 7 (USP7) is higher in human HCC tissues than in matched peritumoral tissues. Ectopic USP7 expression promotes growth of HCC cells in vivo and in vitro. Mechanistically, USP7 overexpression fosters HCC cell growth by forming a complex with and stabilizing thyroid hormone receptor-interacting protein 12 (TRIP12), which induces constitutive p14(ARF) ubiquitination. Clinically, USP7 overexpression is significantly correlated with a malignant phenotype, including larger tumor size, multiple tumor, poor differentiation, elevated alpha-fetoprotein, and microvascular invasion. Moreover, overexpression of USP7 and/or TRIP12 correlates with shorter OS and higher cumulative recurrence rates of HCC. Conclusion: USP7 stabilizes TRIP12 by deubiquitination, thus constitutively inactivating p14(ARF) and promoting HCC progression. This represents a novel marker for predicting prognosis and a potential therapeutic target for HCC. (Hepatology 2015;61:1603-1614)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available